ROBERT FRASER, PH.D.
Chief Operations Officer & Co-Founder
Robert Fraser brings over 14 years of pharmaceutical and biotech research and development.
Dr. Fraser has a strong background and success rate in the development of targeted therapeutics. Driven by the need to better target the therapy to the individual to improve its safety and efficacy, he joined Dr. Cullis at the start of 2011 to establish the PMI for BC, which is a major opportunity for multiple institutions and stakeholders within the province to work together and transform the healthcare in BC.
Prior to joining the PMI, Dr. Fraser was the Group Leader in Target Identification for Sanofi, Senior Director of Biology for Xenon Pharmaceuticals, Senior Director of Pharmacology and Site Director at Neuromed (now Zalicus) and Director Project Evaluation at the Centre for Drug Research and Development (CDRD).